p18 INK4C Antibodies

Santa Cruz Biotechnology features a diverse variety of p18 INK4C monoclonal antibodies for research in cell cycle regulation and tumor suppression. p18 INK4C monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p18 INK4C is a crucial cyclin-dependent kinase inhibitor that plays a significant role in regulating the cell cycle by inhibiting cyclin D-dependent kinases. The function of p18 INK4C is vital in maintaining cellular proliferation and preventing uncontrolled cell growth, making it an important target in cancer research. Dysregulation of p18 INK4C has been implicated in various malignancies, highlighting its significance in understanding tumorigenesis. Researchers can explore the molecular mechanisms of cell cycle control and tumor development through detailed analysis of p18 INK4C expression and activity. Understanding p18 INK4C function contributes to developing new therapeutic approaches for cancer treatment. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cancer biology and cellular regulation mechanisms.